News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
128 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Policy
Kala Pharmaceuticals Announces NDA for INVELTYS (KPI-121 1%) Has Been Accepted for Review by the U.S. FDA
The FDA indicates that the app. is sufficiently complete to permit a substantive review and has set a target action date under the PDUFA of August 24, 2018.
January 5, 2018
·
7 min read
Policy
IDEXX Announces Estimated Impact of U.S. Tax Reform
IDEXX expects the recently passed Tax Cuts and Jobs Act to benefit the Company by reducing its recurring effective tax rate beginning in 2018 by approximately 750-850 basis points.
January 5, 2018
·
3 min read
Genetown
Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Management
Glytec has been awarded another U.S. patent allowance for systems and methods related to insulin management in the outpatient environment.
January 5, 2018
·
3 min read
Biotech Beach
InnerScope Hearing Technologies Retains Barwicki Investor Relations to Provide Global Investor Relations Program
Barwicki Investor Relations is run by Andrew Barwicki, a seasoned veteran with 24 years of marketing and investor relations experience.
January 5, 2018
·
4 min read
Business
Nanowear and The Secant Group Announce Exclusive Supply Chain Partnership for Scaled Manufacturing of Proprietary Cloth-Based Nanosensor Technology
Under the terms of the agreement, Nanowear and The Secant Group will have the collective obligation for marketing the technology and associated products.
January 5, 2018
·
4 min read
Business
Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors
Lapidus has more than 30 years’ experience in the medical diagnostics industry as a founder, CEO and board member at companies that have dramatically impacted the diagnostics landscape, including his founding of EXACT Sciences Corp.
January 5, 2018
·
3 min read
Deals
Crown Laboratories, a Hildred Capital Partners Portfolio Company, Acquires Innovative Self-Tanning Brand Vita Liberata
Crown Laboratories today announced it has acquired Vita Liberata, an Ireland-based company with advanced organic formulations, specializing in sunless tanning and skincare products.
January 5, 2018
·
5 min read
Business
Lilly Confirms Date and Conference Call for Fourth-Quarter 2017 Financial Results Announcement
Eli Lilly will announce its fourth-quarter and full-year 2017 financial results on Wednesday, January 31, 2018.
January 5, 2018
·
1 min read
Business
Helius Medical Technologies Selects Key Tronic Corporation as Its Commercial Contract Manufacturing Partner
The commercial design of the PoNS will be manufactured and assembled at Key Tronic’s facilities located in Oakdale, Minnesota.
January 5, 2018
·
5 min read
Business
Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017
For the full year 2017, total preliminary, unaudited revenue is expected to be $10.1 million, an estimated increase of approximately 200% over 2016.
January 5, 2018
·
4 min read
Previous
6 of 13
Next